INVUS FINANCIAL ADVISORS, LLC Holdings

INVUS FINANCIAL ADVISORS, LLC is an investment fund managing more than 182.19M US dollars. The largest holdings include Coupang, Arcus Biosciences and NovoCure Limited. In Q1 2022 the fund bought assets of total value of 228K US dollars and sold assets of total value of 40.71M US dollars.

$182.19M

portfolio value

+10.00%

quarter

-43.41%

1 year

INVUS FINANCIAL ADVISORS, LLC portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2021	225262000	7670000
Q4 2021	16700000	56317000
Q1 2022	228000	40711000

INVUS FINANCIAL ADVISORS, LLC 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Internet Retail Coupang, Inc. Portfolio share: 27.88% Portfolio value: 50.78M Avg. open price: N/A Current price: $17.91 P/L: N/A Sold -3.73% shares Q1 2022	share	27.88%	50.78M	N/A	$17.91	N/A	Sold -3.73% shares Q1 2022
Biotechnology Arcus Biosciences, Inc. Portfolio share: 23.15% Portfolio value: 42.17M Avg. open price: N/A Current price: $33.96 P/L: N/A Sold -12.49% shares Q4 2021	share	23.15%	42.17M	N/A	$33.96	N/A	Sold -12.49% shares Q4 2021
Medical Instruments & Supplies NovoCure Limited Portfolio share: 14.63% Portfolio value: 26.66M Avg. open price: N/A Current price: $78 P/L: N/A Sold -25.48% shares Q3 2020	share	14.63%	26.66M	N/A	$78	N/A	Sold -25.48% shares Q3 2020
Banks—Diversified Nu Holdings Ltd. Portfolio share: 13.48% Portfolio value: 24.56M Avg. open price: N/A Current price: $4.06 P/L: N/A N/A Q2 2022	share	13.48%	24.56M	N/A	$4.06	N/A	N/A Q2 2022
Biotechnology Oyster Point Pharma, Inc. Portfolio share: 8.54% Portfolio value: 15.55M Avg. open price: $35 Current price: $11.11 P/L: -68.26% Bought +6.89% shares Q2 2020	share	8.54%	15.55M	$35	$11.11	-68.26%	Bought +6.89% shares Q2 2020
Internet Content & Information Taboola.com Ltd. Portfolio share: 7.77% Portfolio value: 14.15M Avg. open price: N/A Current price: $2.68 P/L: N/A Sold -0.58% shares Q4 2021	share	7.77%	14.15M	N/A	$2.68	N/A	Sold -0.58% shares Q4 2021
Computer Hardware IonQ, Inc. Portfolio share: 2.78% Portfolio value: 5.07M Avg. open price: N/A Current price: $4.65 P/L: N/A N/A Q4 2021	share	2.78%	5.07M	N/A	$4.65	N/A	N/A Q4 2021
Biotechnology ORIC Pharmaceuticals, Inc. Portfolio share: 1.77% Portfolio value: 3.22M Avg. open price: N/A Current price: $4.02 P/L: N/A Sold -0.00% shares Q4 2020	share	1.77%	3.22M	N/A	$4.02	N/A	Sold -0.00% shares Q4 2020

Showing TOP 8 INVUS FINANCIAL ADVISORS's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of INVUS FINANCIAL ADVISORS, LLC?

The biggest position of the INVUS FINANCIAL ADVISORS, LLC is Coupang, Inc. (CPNG) with 27.88% portfolio share worth of 50.79M US dollars.

Top 5 INVUS FINANCIAL ADVISORS's holdings represent 87.68% of the portfolio:

Coupang, Inc. (CPNG) – 27.88%
Arcus Biosciences, Inc. (RCUS) – 23.15%
NovoCure Limited (NVCR) – 14.63%
Nu Holdings Ltd. (NU) – 13.48%
Oyster Point Pharma, Inc. (OYST) – 8.54%

Who is the portfolio manager of INVUS FINANCIAL ADVISORS, LLC?

The portfolio manager of the INVUS FINANCIAL ADVISORS, LLC is .

What is the total asset value of the INVUS FINANCIAL ADVISORS, LLC portfolio?

INVUS FINANCIAL ADVISORS, LLC total asset value (portfolio value) is 182.19M US dollars.

Who is ?

is the portfolio manager of the INVUS FINANCIAL ADVISORS, LLC.

What is (INVUS FINANCIAL ADVISORS, LLC) fund performance?

INVUS FINANCIAL ADVISORS's quarterly performance is +10.00%, annualy -43.41%.

What is the INVUS FINANCIAL ADVISORS, LLC CIK?

INVUS FINANCIAL ADVISORS's Central Index Key is 0001802978 .